Highlights of the BMC Series – February 2024
Is possible to reduce the incidence of preeclampsia in primigravid women with vitamin D supplementation? How can we enhance parenting skills with dedicated… Read more »
Lorena has a master’s degree in Biomolecular Sciences and Technologies (University of Pisa, Pisa, Italy) and a PhD in Innovative Strategies in Biomedical Research (Scuola Superiore Sant’Anna, Pisa, Italy). After her PhD she worked in research institutes, universities and life science companies in Italy and in the UK, including the Italian National Cancer Institute "Regina Elena" in Rome, "Sapienza" Università di Roma, Rome, Italy, and the University of Cambridge, Cambridge, UK. Her research focused on cardiovascular regeneration, role of microRNAs and circRNAs in cancer, assessment of new cancer drug in vitro and in vivo, and development of new technologies. Before joining BMC Public Health in September 2022, Lorena was an Associate Editor at PLOS ONE in the Public Health and Medicine Team.
Latest posts by Lorena Verduci (see all)
- Highlights of the BMC Series – February 2024 - 21st March 2024
- APHA 2023: Creating the Healthiest Nation - 14th December 2023
- Highlights of the BMC Series – June 2023 - 18th July 2023
APHA 2023: Creating the Healthiest Nation
The American Public Health Association (APHA) Annual Meeting & Expo is the largest public health conference globally. This year’s meeting builds on over… Read more »
Highlights of the BMC Series – June 2023
Can laughter yoga enhance the quality of life of cancer patients undergoing chemotherapy? -- How do general practitioners manage patients with knee pain… Read more »